Provided by Tiger Trade Technology Pte. Ltd.

NanoViricides

1.31
-0.1300-9.03%
Post-market: 1.330.0200+1.53%16:23 EDT
Volume:289.76K
Turnover:385.14K
Market Cap:33.40M
PE:-3.22
High:1.42
Open:1.38
Low:1.30
Close:1.44
52wk High:2.23
52wk Low:0.8500
Shares:25.50M
Float Shares:24.90M
Volume Ratio:0.82
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4071
EPS(LYR):-0.4071
ROE:-101.46%
ROA:-55.53%
PB:3.85
PE(LYR):-3.22

Loading ...

NanoViricides proposes Phase II trial of NV-387 gummies in Ebola

TIPRANKS
·
Jun 08

NanoViricides Files for $50 Million Mixed Shelf Offering

MT Newswires Live
·
Jun 06

NanoViricides files $50M mixed securities shelf

TIPRANKS
·
Jun 06

NanoViricides - Files to Offer up to $50 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Jun 06

Top Premarket Gainers

MT Newswires Live
·
May 27

Analysts Are Bullish on These Healthcare Stocks: Evogene (EVGN), NanoViricides (NNVC)

TIPRANKS
·
May 27

NanoViricides says NV-387 oral gummies ready to ship to DRC for Phase II mpox trial amid Ebola outbreak

Reuters
·
May 26

NanoViricides Highlights NV-387 Strategy for Ebola Outbreak

TIPRANKS
·
May 21

NanoViricides says NV-387 candidates expected to work against Congo Bundibugyo Ebola strain

Reuters
·
May 21

NanoViricides Completes $2 Million Registered Direct Offering

TIPRANKS
·
May 21

NanoViricides closes US$2 million registered direct offering priced at US$1.5 share

Reuters
·
May 19

EXPLAINER-What do we know about the Bundibugyo strain of the Ebola virus?

Reuters
·
May 19

NanoViricides emphasizes need for Ebolavirus antiviral drug

TIPRANKS
·
May 18

NanoViricides prices US$2 million registered direct offering with warrants

Reuters
·
May 15

NanoViricides Q3 FY26 net loss narrows to $1.99 million; R&D expenses rise to $1.29 million

Reuters
·
May 15

NanoViricides says hantavirus incident highlights need for antiviral drugs

TIPRANKS
·
May 11

NanoViricides says FDA grants orphan drug designation to NV-387 for measles treatment

Reuters
·
May 04

NanoViricides measles virus treatment granted FDA orphan status

TIPRANKS
·
Apr 29

NanoViricides says NV-387 can help control spread of measles

TIPRANKS
·
Apr 21

NanoViricides applies for FDA orphan, rare pediatric designations for measles drug NV-387

Reuters
·
Apr 21